2017 Wyss Zurich Annual Event
Patient recruitment has started
ETIMSred starts clinical phase Ib study “Immune tolerance in multiple sclerosis with peptide-coupled red blood cells"
Wyss Zurich Project hemotune wins finals
Associate Project PATHOS successfully presented first pieces at ART BASEL
WINNER OF DE VIGIER AWARD 2017
Daniela Marino, CEO of CUTISS AG and Co-Project Leader of Wyss Zurich Project denovoSkin, is winner of the prestigious DeVigier Award 2017
New project launched
hemotune: restoring immune balance in sepsis – a Wyss Zurich project
Partial ISO 13485 QMS
Wyss Zurich implements product development processes in alignment with ISO 13485 requirements to support and accelerate medical device projects
Wyss Zurich brings together the excellence of ETH Zurich and the University of Zurich in the emerging fields of Regenerative Medicine and Robotics
Enhancing the interaction skills and mobility of robots
Enhancing the regeneration of the injured central nervous system
Personalized skin grafts to treat skin defects
Establishing immune tolerance in Multiple Sclerosis
Restoring immune balance in sepsis
Improving the biocompatibility of medical implants
Tissue-engineered human matrices to repair and regenerate the heart
Regeneration of the human liver outside of the body
Flying robots that take-off and land like helicopters, but fly like planes
Poetic Animatronics Through Hands-On Systems
Train a Robot. Learn Science.
A modular system of application-specific prosthetic hands for children and adolescents
Replicating the human visual perception for robots
satw – detection: Robots, the useful high-tech helpers
Survey to improve arm prosthesis: Participate now!
50th Anniversary of the 1st Heart Transplant
Basil Weibel – An idealist who builds drones
Interdisciplinary Colloquium Regenerative Medicine I - November 28, 2017
SRF 10Vor10 - Thurdsay, November 16, 2017 – Are maglev trains the means of transport of the future?
CUTISS AG awarded with prestigious CTI Start up Label
futurezone – Silicon Valley takes artificial Intelligence Talent away from Universities
CUTISS AG receives Swissmedic approval to commence Pivotal Phase II denovoSkin™ trials in burns in adults and children.
Hansjörg Wyss is Master Entrepreneur
Interdisciplinary Colloquium Regenerative Medicine I - October 31, 2017
Wyss Zurich Core Faculty members are leaders in the field of Regenerative Medicine and Robotics.
The state-of-the-art technology platforms support the advancement of the Wyss Zurich projects.
ETH Zurich / University of Zurich
Weinbergstrasse 35, WEH